Valion Bio, Inc. · Brief

Next report

11 days

Nov 16 · after closeest.Q3 FY26

Expected move

No implied move.

No reported quarters.

Nov 16 report · est.

—

VBIO report session

No linked exposure.

Oct 278-KMaterial agreement: letter agreement with 3i, LP.Source

Oct 88-KMaterial agreement: Securities Purchase Agreement; letter agreement (Third Side Letter) with 3i, LP.Source

privateThesis 0 · Decisions 0 · Observations 0

No thesis.